Latest Stories
Featured Stories
Explore inspiring journeys of recovery and resilience as patients share their experiences with Padaav’s root-cause-focused, evidence-based Ayurvedic treatments, highlighting the power of personalized care and holistic healing.
Feedback
All Stories
Delve into the heartfelt experiences of patients who have transformed their health and lives with Padaav’s research-backed Ayurvedic care, showcasing the impact of addressing root causes for lasting recovery.
Hamad Alam
Rectal Adenocarcinoma
New Delhi
Hamad’s struggle reached a terrifying peak in 2018 while traveling back to Delhi from a cou…
Patient Name
Acute Recurrent Pancreatitis
Kotdwar, Uttarakhand.
Shilpi’s struggle began suddenly during her 10th-grade school break, when she felt a sharp …
Anurag Goyal
Investment Banker
New Delhi
Anurag’s struggle began suddenly in the midnight of September 2010, when he experienced exc…
Sumit Kumar
Pancreas Divisum with secondary Chronic Pancreatitis
Dehradun, Uttarakhand
Sumit suffered from Pancreas Divisum, a congenital anomaly where the two pancreatic ducts (the ve…
Aviral Saxena
Chronic Pancreatitis with Secondary Diabetes
Dehradun, Uttarakhand
Aviral’s journey began in November 2022 while he was actively working as a freelancer. The …
Rajeev Sharma
Chronic Pancreatitis
Dehradun, Uttarakhand
Rajeev’s journey began with mild symptoms in 2009, potentially following a physical encount…
Research
Our Research
At Padaav, alongside delivering unparalleled patient care and promoting holistic health, we are committed to advancing Ayurveda by actively participating in research and contributing to its growing body of knowledge.
Ayurvedic treatment protocol in the management of pancreatitis: A nonrandomized observational study
A North Indian clinic treated 1750 recurrent pancreatitis patients (1997–2023) with an ayurvedic Herbo-Mineral Formulation (HMF). Among 916 completing 1-year treatment, attacks reduced by 93%, hospitalizations by 97%, with no adverse effects. Long-term remission supports further clinical trials.
Herbo-mineral ayurvedic treatment in a high risk acute promyelocytic leukemia patient with second relapse: 12 years follow up
A 47-year-old diabetic male with high-risk AML-M3 relapsed after multiple chemotherapy treatments. In 1997, he opted for a pilot Ayurvedic study and was treated with Navajeevan, Kamadudha Rasa, and Keharuba Pisti. He achieved complete remission and has remained disease-free for 13 years without side effects from the alternative treatment.
Clinical Intervention of Ayurvedic Treatment in the Patients of Recurrent Acute/Chronic Pancreatitis
The study of 1233 acute pancreatitis patients found that 12.9% experienced oral feeding intolerance (OFI). Risk factors included younger age, male sex, alcohol use, smoking, non-biliary etiology, and SIRS at 48h. SIRS at 48h (OR 2.85) and non-biliary etiology (OR 1.77) were independently linked to OFI, with biliary etiology being protective.
Prevalence of Anemia among Pregnant Women and Adolescent Girls in 16 Districts of India
Nutritional anemia is widespread in India, affecting 84.9% of pregnant women and 90.1% of adolescent girls. Severe anemia is prevalent in both groups. The Government of India provides iron and folic acid to pregnant women, but no similar program exists for adolescent girls. Interventions should address iron, B12, and folic acid deficiencies.
Proof of Efficacy Study to Evaluate an Ayurvedic Formulation in the Treatment of Allergic Rhinitis: An Open Label Randomized Controlled Clinical Trial
A study on 250 patients compared the Ayurvedic formulation IMMBO to a levocetirizine-montelukast combination for allergic rhinitis. IMMBO showed significantly greater improvements in symptoms (TNSS: -5.70 vs. -3.31) and IgE reduction (-351.54 vs. -208.79), demonstrating superior efficacy and safety.
Sustainable Effect of Ayurvedic Formulations in the Treatment of Nutritional Anemia in Adolescent Students
This study evaluated the impact of Ayurvedic treatments (Sootshekhar Rasa and Sitopaladi Churna) on nutritional anemia in 1322 adolescent students in Dehradun. After 90 days of treatment, significant hemoglobin improvements were seen in the treatment groups, especially those receiving a daily dose of 250 mg SR and 400 mg SC. The study concluded that this combination effectively improves anemia in adolescents without adverse effects.